These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

100 related articles for article (PubMed ID: 3334664)

  • 61. [Bromocriptine in metastasizing breast cancer].
    Schulz KD
    Dtsch Med Wochenschr; 1979 May; 104(18):652. PubMed ID: 376262
    [No Abstract]   [Full Text] [Related]  

  • 62. New developments in the treatment of metastatic breast cancer: from chemotherapy to biological therapy.
    Mariani G
    Ann Oncol; 2005; 16 Suppl 2():ii191-4. PubMed ID: 15958455
    [No Abstract]   [Full Text] [Related]  

  • 63. Disseminated breast cancer: evaluation of hormonal therapy utilizing stilbestrol and medrogestone (AY-62022) singly and in combination.
    Ahmann DL; Hahn RG; Bisel HF
    Cancer; 1972 Sep; 30(3):651-3. PubMed ID: 4561631
    [No Abstract]   [Full Text] [Related]  

  • 64. Chemotherapy in advanced breast cancer.
    Gundersen S; Kvinnsland S
    Acta Oncol; 1987; 26(2):81-7. PubMed ID: 3300710
    [No Abstract]   [Full Text] [Related]  

  • 65. Early stopping of trials.
    Hopf G
    Lancet; 1997 Sep; 350(9081):891. PubMed ID: 9310635
    [No Abstract]   [Full Text] [Related]  

  • 66. In vivo manipulation of human breast cancer growth by estrogens and growth hormone: kinetic and clinical results.
    Conte PF; Gardin G; Pronzato P; Miglietta L; Rosso R; Amadori D; Gentilini P; Monzeglio C; Gallotti P; Demicheli R
    J Steroid Biochem Mol Biol; 1990 Dec; 37(6):1103-8. PubMed ID: 1981014
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Attrition in metastatic breast cancer: a metric to be reported in randomised clinical trials?
    Nuzzolese I; Montemurro F
    Lancet Oncol; 2020 Jan; 21(1):21-24. PubMed ID: 31908294
    [No Abstract]   [Full Text] [Related]  

  • 68. The treatment of cancer in an aging population.
    Harris JE
    JAMA; 1992 Jul; 268(1):96-7. PubMed ID: 1608119
    [No Abstract]   [Full Text] [Related]  

  • 69. Progress in chemotherapy for metastatic breast cancer.
    Sledge GW; Antman KH
    Semin Oncol; 1992 Jun; 19(3):317-32. PubMed ID: 1609297
    [No Abstract]   [Full Text] [Related]  

  • 70. Diethylstilbestrol in breast cancer: dose-response analysis.
    Wittes JT; Kaufman RJ; Wittes RE
    JAMA; 1977 Sep; 238(13):1362-3. PubMed ID: 578187
    [No Abstract]   [Full Text] [Related]  

  • 71. Selected Articles from This Issue.
    Clin Cancer Res; 2020 Apr; 26(7):1533. PubMed ID: 32238409
    [No Abstract]   [Full Text] [Related]  

  • 72. [Evaluation of regimens for the simultaneous and sequential administration of cytostatics in the combined chemotherapy of disseminated forms of breast cancer].
    Korman DB; Borisov AI; Maslova IA; Pines EV
    Vopr Onkol; 1985; 31(5):21-6. PubMed ID: 3925630
    [TBL] [Abstract][Full Text] [Related]  

  • 73. [Comparison of epirubicin and cyclophosphamide in 2-dose levels and classical CMF protocol in node-positive breast cancer. An adjuvant Phase III trial].
    Ost E; Illiger HJ
    Strahlenther Onkol; 2002 Jan; 178(1):54-5. PubMed ID: 11977396
    [No Abstract]   [Full Text] [Related]  

  • 74. [Importance of dose intensity in chemotherapy--lessons from adjuvant chemotherapy for early breast cancer].
    Tamura K
    Rinsho Ketsueki; 2009 Apr; 50(4):276-81. PubMed ID: 19404020
    [No Abstract]   [Full Text] [Related]  

  • 75. Evaluation of the importance and relevance of dose intensity using epirubicin and cyclophosphamide in metastatic breast cancer: interim analysis of a prospective randomized trial.
    Marschner N; Kreienberg R; Souchon R; Räth U; Eggeling B; Voigtmann R; Ruffert K; Schütte M; Ammon A; Kesztyüs T
    Semin Oncol; 1994 Feb; 21(1 Suppl 1):10-6. PubMed ID: 8153652
    [No Abstract]   [Full Text] [Related]  

  • 76. Sclerotic and retracted supravenous hyperpigmentation associated with combination chemotherapy for metastatic breast carcinoma.
    Chen GY; Lee JY; Chen WC
    Br J Dermatol; 2005 Jun; 152(6):1383-5. PubMed ID: 15949026
    [No Abstract]   [Full Text] [Related]  

  • 77. Cytokinetic-based versus conventional chemotherapy in metastatic breast cancer: a randomized study.
    Conte PF; Rubagotti A; Falcone A; Gardin G; Nicolin A; Pronzato P; Rosso R; Amadori D; Gentilini P; Sismondi P
    Chemioterapia; 1987 Jun; 6(2 Suppl):712-3. PubMed ID: 3334664
    [No Abstract]   [Full Text] [Related]  

  • 78. [Chemotherapy protocol with taxol increase survival by 31 percent].
    Krankenpfl J; 2002; 40(7-9):226. PubMed ID: 12514866
    [No Abstract]   [Full Text] [Related]  

  • 79.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 80.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.